A patient in New York has been infected with a strain of E. coli highly resistant to last-resort antibiotic treatments, according to an article on the Becker's Infection Control and Clinical Quality website.
This is the second U.S. patient with the untreatable superbug infection, following a Pennsylvania patient first made public last month.
The mcr-1 gene gives bacteria resistance to colistin, a last-line-of-defense antibiotic used to combat a number of resistant microorganisms.
Going into 2017, the White House has requested $1.1 billion be allocated to efforts to combat antibiotic resistance in the U.S.
Laser Scanning: Reducing Risk in Construction Projects
MOBs Get Smarter and More Complex as Space Pressures Mount
Ascension Saint Thomas Sets Date for Groundbreaking on New Hospital and Health Campus
Women in Construction Sees Growth on Florida Jobsite
Managing Soft Surfaces, Clean or Soiled